The M&A-focused Betaville blog sent an alert to its subscribers related to a rumor regarding Soleno Therapeutics (SLNO), contacts tell The Fly. Soleno shares are up 58c, or 1% to $82.00 in morning trading.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SLNO:
- DoorDash, AMD upgraded: Wall Street’s top analyst calls
- Soleno Therapeutics initiated with a Buy at TD Cowen
- Soleno Therapeutics Holds Annual Stockholders Meeting
- Soleno Therapeutics seeking regulatory approval in treatment of PWS
- Soleno Therapeutics presents Vykat XR data at Pediatric Endocrine Society